Transparency Market Research includes new market research report "HPV Testing Market - Global Industry Size, Share, Trends, Analysis, And Forecasts 2012 - 2018" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 02/17/2014 -- The cancer diagnostics market is on the verge of sudden increase due to the technological breakthroughs in tumor diagnosis and unlocking of mysteries of genetics. The HPV (Human Papilloma Virus) testing market is expected to witness a promising growth in the next few years due to rising incidences of cancerous tumors and the growing ageing population.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/hpv-testing-market.html
Predictable technological breakthroughs are creating a number of opportunities for genetic study, detecting specific tumors, and monitoring biological responses to cancer therapy. Rise in the elderly population will further complicate the growing demand for malignancy assays and the rapid expansion of market worldwide.
- Monoclonal and Polyclonal Antibodies
- Molecular Diagnostics
- Chromosome Analysis
- Microcomputers and Automation
- Artificial Intelligence
- Flow Cytometry
This research report on the HPV testing analyzes the market segments and major geographies. This report provides a complete analysis of current market trends, industry growth drivers, restraints, industry structure, and market projections for the coming years. It also includes analysis of current technological developments, Porter’s five force analysis, and detailed company profiles of the top market players. This research report includes a review of the micro and macro factors significant for the existing market players and new entrants along with detailed value chain analysis.
The major geographies analyzed under this research study are North America, the Asia-Pacific, Europe, and the Rest of the World.
The major players in the field of the HPV testing are Abbott, AdnaGen, Ambrilia Biopharma, AMDL, Beckman Coulter, Becton Dickinson, Biomedical Diagnostics, bioMerieux, Bio-Rad, CanAG Diagnostics, CeMines, Cepheid, Correlogic Systems, Dako, Decode, Diadexus, Diagnocure, Diasorin, Eiken Chemical, Enterix, Enzo Biochem, Epigenomics, Exact Sciences, Fujirebio, Gen-Probe, Guided Therapeutics, Hologic, Ipsogen, J&J Diagnostics, Kreatech, Kyowa Medex, Mackay Life Sciences, Matritech, Myriad Genetics, OncoLab, Panacea Pharmaceuticals, Polartechnics, Polymedco, PreMD, Qiagen, Radient, Pharmaceuticals, Roche, Scienion, Sequenom, Siemens Healthcare, Takara Bio, Targeted Diagnostics & Therapeutics, Tosoh, Veridex, Wako Pure Chemicals, Wallac, Zila, and others.
Read More Reports on Pharmaceutical Markets: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information.Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
90 State Street,
Albany NY - 12207
Browse Market Research Blog:
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)